OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A review of the BCG vaccine and other approaches toward tuberculosis eradication
Thomas Cho, Christopher Khatchadourian, Nguyễn Đức Huy, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 8, pp. 2454-2470
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Galleria mellonella–intracellular bacteria pathogen infection models: the ins and outs
Masanori Asai, Yan-Wen Li, Sandra M. Newton, et al.
FEMS Microbiology Reviews (2023) Vol. 47, Iss. 2
Open Access | Times Cited: 31

VIRTUAL SCREENING OF FDA-APPROVED DRUGS BY MOLECULAR DOCKING AND DYNAMICS SIMULATION TO RECOGNIZE POTENTIAL INHIBITORS AGAINST MYCOBACTERIUM TUBERCULOSIS ENOYL-ACYL CARRIER PROTEIN REDUCTASE ENZYME
Hasanain Abdulhameed Odhar, Ahmed Fadhil Hashim, Salam Waheed Ahjel, et al.
International Journal of Applied Pharmaceutics (2024), pp. 261-266
Open Access | Times Cited: 6

Immunological effects of the PE/PPE family proteins of Mycobacterium tuberculosis and related vaccines
Fangzheng Guo, Jing Wei, Yamin Song, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12

Adenoviral vaccines—Infectious disease
Carly M. Bliss, Gerardo Montalvo Zurbia-Flores, Daniel Wright, et al.
Elsevier eBooks (2025), pp. 573-642
Closed Access

Evaluation of the immunogenic potential of recombinant Mycobacterium bovis BCG expressing the ASP-2 and TC24 proteins from Trypanosoma cruzi
Gabriela dos Santos, Bárbara da Rocha Fonseca, Fernanda Severo Sabedra Sousa, et al.
Acta Tropica (2025), pp. 107569-107569
Closed Access

Mycobacterium tuberculosis and SARS-CoV-2 co-infections: The knowns and unknowns
Kim R Chiok, Neeraj Dhar, Arinjay Banerjee
iScience (2023) Vol. 26, Iss. 5, pp. 106629-106629
Open Access | Times Cited: 8

BCG mediated protection of the lung against experimental SARS-CoV-2 infection
Kerry L. Hilligan, Sivaranjani Namasivayam, Alan Sher
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8

Liposomal delivery system/adjuvant for tuberculosis vaccine
Melika Moradi, Farzaneh Vahedi, Arian Abbassioun, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 7

BCG-induced trained immunity enhances acellular pertussis vaccination responses in an explorative randomized clinical trial
Joshua Gillard, Bastiaan A. Blok, Daniel Garza, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 12

Effects of non-tuberculous mycobacteria on BCG vaccine efficacy: A narrative review
Fatemeh Ghasemi, Jalil Kardan-Yamchi, Mohsen Heidary, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases (2024) Vol. 36, pp. 100451-100451
Open Access | Times Cited: 2

IV BCG Vaccination and Aerosol BCG Revaccination Induce Mycobacteria-Responsive γδ T Cells Associated with Protective Efficacy against M. tb Challenge
Alexandra L. Morrison, Charlotte Sarfas, Laura Sibley, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1604-1604
Open Access | Times Cited: 5

An Immunoinformatics-Based Study of Mycobacterium tuberculosis Region of Difference-2 Uncharacterized Protein (Rv1987) as a Potential Subunit Vaccine Candidate for Preliminary Ex Vivo Analysis
Aregitu Mekuriaw Arega, Ajit Kumar Dhal, Kali Prasad Pattanaik, et al.
Applied Biochemistry and Biotechnology (2023) Vol. 196, Iss. 4, pp. 2367-2395
Open Access | Times Cited: 3

Epigenetics of Pulmonary Tuberculosis
Madan M. Gupta, Ritu Gilhotra, Deepika Deopa, et al.
(2023), pp. 127-144
Closed Access | Times Cited: 3

Ending the TB pandemic: the urgency of a new and improved TB vaccine and the World Health Organization's TB Vaccine Accelerator Council
Victor Abiola Adepoju, Okechukwu Innocent Onyezue
Breathe (2023) Vol. 19, Iss. 3, pp. 230036-230036
Open Access | Times Cited: 2

Oral Bacille Calmette-Guérin (BCG) vaccination induces long-term potentiation of memory immune response to Ovalbumin airway challenge in mice.
Andreza Hammes, Fabı́ola Cardillo, Rodolfo Frota, et al.
Immunology Letters (2022) Vol. 249, pp. 43-52
Closed Access | Times Cited: 4

Vaccines and Vaccine Response in the Small Bowel Transplant Patient
Florence Lacaille
Gastroenterology Clinics of North America (2024) Vol. 53, Iss. 3, pp. 431-439
Closed Access

Construction and expression of Mycobacterium tuberculosis fusion protein SHR3 and its immunogenicity analysis in combination with various adjuvants
Zian Zhang, Lifa Xu, Xiaochun Wang, et al.
Tuberculosis (2024) Vol. 145, pp. 102480-102480
Closed Access

A rare case of osteoarticular tuberculosis and tuberculous osteomyelitis of the left foot without pulmonary involvement
Rithika Ramadugu, Tarun Kumar Suvvari, Sameera Ramadugu, et al.
Radiology Case Reports (2024) Vol. 19, Iss. 12, pp. 6609-6613
Open Access

Bacillus Calmette-Guérin (BCG) Vaccine in America and Overseas: A Narrative Review
Alan D. Kaye, Trevor P. Giles, Emily C. O’Brien, et al.
Cureus (2024)
Open Access

Tuberculosis Vaccines
Willem A. Hanekom, Thomas R. Hawn, Ann M. Ginsberg
Elsevier eBooks (2023), pp. 1158-1176.e8
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top